Versant Voyageurs I Parallel, L.P.
CIK 0001745961 Name as filed on the most recent filing
Filed as Versant Voyageurs I Parallel, L.P. (18)
77 transaction lines · from 18 filings · filed 2020-02-05 to 2024-08-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2020-10-16 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 1,016 disposed | 33.57 | 34,109.96 | Form 4, filing 0000899243-20-028811 | |
| 2020-10-15 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 2,473 disposed | 33.03 | 81,693.82 | Form 4, filing 0000899243-20-028811 | |
| 2020-10-15 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 327 disposed | 33.03 | 10,802.22 | Form 4, filing 0000899243-20-028811 | |
| 2020-10-14 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 4,859 disposed | 33.09 | 160,787.23 | Form 4, filing 0000899243-20-028366 | |
| 2020-10-14 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 642 disposed | 33.09 | 21,244.17 | Form 4, filing 0000899243-20-028366 | |
| 2020-10-13 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 10,370 disposed | 33.39 | 346,270.89 | Form 4, filing 0000899243-20-028366 | |
| 2020-10-13 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 1,369 disposed | 33.39 | 45,713.10 | Form 4, filing 0000899243-20-028366 | |
| 2020-10-12 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 353 disposed | 33.11 | 11,686.95 | Form 4, filing 0000899243-20-028070 | |
| 2020-10-12 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 47 disposed | 33.11 | 1,556.05 | Form 4, filing 0000899243-20-028070 | |
| 2020-10-09 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 3,357 disposed | 33.67 | 113,018.44 | Form 4, filing 0000899243-20-028070 | |
| 2020-10-09 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 443 disposed | 33.67 | 14,914.26 | Form 4, filing 0000899243-20-028070 | |
| 2020-10-08 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 8,502 disposed | 33.68 | 286,352.46 | Form 4, filing 0000899243-20-028070 | |
| 2020-10-08 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 7,774 disposed | 33.25 | 258,461.40 | Form 4, filing 0000899243-20-028070 | |
| 2020-10-08 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 1,122 disposed | 33.68 | 37,789.63 | Form 4, filing 0000899243-20-028070 | |
| 2020-10-08 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 1,027 disposed | 33.25 | 34,144.57 | Form 4, filing 0000899243-20-028070 | |
| 2020-10-07 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 24,590 disposed | 33.56 | 825,154.34 | Form 4, filing 0000899243-20-027852 | |
| 2020-10-07 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 3,246 disposed | 33.56 | 108,924.40 | Form 4, filing 0000899243-20-027852 | |
| 2020-10-06 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 15,980 disposed | 33.26 | 531,477.22 | Form 4, filing 0000899243-20-027852 | |
| 2020-10-06 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 2,110 disposed | 33.26 | 70,176.28 | Form 4, filing 0000899243-20-027852 | |
| 2020-08-11 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 6,692 disposed | 33.08 | 221,380.06 | Form 4, filing 0000899243-20-022188 | |
| 2020-08-11 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 883 disposed | 33.08 | 29,210.79 | Form 4, filing 0000899243-20-022188 | |
| 2020-08-10 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 5,492 disposed | 33.04 | 181,445.79 | Form 4, filing 0000899243-20-022188 | |
| 2020-08-10 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 725 disposed | 33.04 | 23,952.70 | Form 4, filing 0000899243-20-022188 | |
| 2020-02-03 |
Black Diamond Therapeutics, Inc. BDTX |
P, Open-market purchase | 396,082 acquired | 19.00 | 7,525,558.00 | Form 4, filing 0000899243-20-003371 | |
| 2020-02-03 |
Black Diamond Therapeutics, Inc. BDTX |
P, Open-market purchase | 396,081 acquired | 19.00 | 7,525,539.00 | Form 4, filing 0000899243-20-003371 | |
| 2020-02-03 |
Black Diamond Therapeutics, Inc. BDTX |
P, Open-market purchase | 79,013 acquired | 19.00 | 1,501,247.00 | Form 4, filing 0000899243-20-003371 | |
| 2020-02-03 |
Black Diamond Therapeutics, Inc. BDTX |
P, Open-market purchase | 23,560 acquired | 19.00 | 447,640.00 | Form 4, filing 0000899243-20-003371 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Versant Voyageurs I Parallel, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001745961
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6